Agendia
FINA FONT BOSCH is an experienced Sales Manager currently overseeing Agendia's operations in Spain and Portugal, focusing on the commercialization of the genetic test MammmaPrint since November 2018. Previously, FINA held various roles at Ferrer, including Diagnostics Area Manager and Oncopharma Marketing and Sales Manager, where responsibilities included oncological diagnostic platforms. FINA has also worked as a Biotech Specialist at Progenika and held multiple positions at Lacer, including Sales Management and Technical Responsibility in in vitro diagnostics. FINA's career began at Bristol-Myers Squibb as a Sales Specialist in the cardiovascular sector and included an early role as a Medical Sales Delegate at ASTA MEDICAL LIMITED. FINA holds a Licenciatura in Pharmacy and a specialization in Microbiology and Parasitology from the Universitat de Barcelona.
This person is not in any offices
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.